Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

被引：1

作者：

Cochrane, Tara ^{[1
,2
]}

Campbell, Belinda A. ^{[3
,4
,5
]}

Gangatharan, Shane A. ^{[6
,7
]}

Latimer, Maya ^{[8
]}

Khor, Richard ^{[9
]}

Christie, David R. H. ^{[10
,11
]}

Gilbertson, Michael ^{[12
,13
,14
]}

Ratnasingam, Sumita ^{[15
]}

Palfreyman, Emma ^{[16
]}

Lee, Hui-Peng ^{[17
]}

Trotman, Judith ^{[18
,19
]}

Hertzberg, Mark ^{[20
,21
]}

Dickinson, Michael ^{[5
,22
,23
]}

机构：

[1] Gold Coast Univ Hosp, Dept Haematol, Gold Coast, Qld, Australia

[2] Griffiths Univ, Sch Med, Gold Coast, Qld, Australia

[3] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia

[4] Univ Melbourne, Dept Clin Pathol, Parkville, Vic, Australia

[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[6] Fiona Stanley Hosp, Perth, WA, Australia

[7] Univ Western Australia, Perth, WA, Australia

[8] ACT Pathol & Canberra Hosp, Canberra, ACT, Australia

[9] Austin Hosp, Melbourne, Vic, Australia

[10] Genesiscare, Gold Coast, Qld, Australia

[11] Bond Univ, Gold Coast, Qld, Australia

[12] Monash Hlth, Melbourne, Vic, Australia

[13] Monash Univ, Sch Clin Sci, Melbourne, Vic, Australia

[14] Western Hlth, Dept Haematol & Oncol, Melbourne, Vic, Australia

[15] Univ Hosp Geelong, Andrew Love Canc Ctr, Geelong, Vic, Australia

[16] Royal Darwin Hosp, Darwin, NT, Australia

[17] Flinders Med Ctr, Adelaide, SA, Australia

[18] Concord Repatriat Gen Hosp, Sydney, NSW, Australia

[19] Univ Sydney, Sydney, NSW, Australia

[20] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia

[21] Univ NSW, Sydney, NSW, Australia

[22] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[23] Royal Melbourne Hosp, Melbourne, Vic, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 12期

关键词：

Hodgkin lymphoma; PET adapted; chemotherapy; HL; radiotherapy; BREAST-CANCER RISK; POSITRON-EMISSION-TOMOGRAPHY; ACUTE MYELOID-LEUKEMIA; PRIMARY THYROID-CANCER; RADIATION-THERAPY; CHILDHOOD-CANCER; OPEN-LABEL; BRENTUXIMAB VEDOTIN; ADAPTED TREATMENT; PROGNOSTIC SCORE;

D O I：

10.1111/imj.15503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.

引用

页码：2119 / 2128

页数：10

共 50 条

[1] Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Barraclough, Allison
Tang, Catherine
Lasica, Masa
Smyth, Elizabeth
Cirillo, Melita
Mutsando, Howard
Cheah, Chan Y.
Ku, Matthew
INTERNAL MEDICINE JOURNAL, 2025, 55 (01) : 117 - 129
[2] Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Tobin, Joshua W. D.
Hapgood, Greg
Johnston, Anna
Cheah, Chan Y.
Lee, Sze T.
Trotman, Judith
Inam, Shafqat
Campbell, Belinda A.
Norris, Debbie
MacManus, Michael
Hertzberg, Mark
Hawkes, Eliza
INTERNAL MEDICINE JOURNAL, 2024, 54 (08) : 1384 - 1395
[3] Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Keane, Colm
Hamad, Nada
Barraclough, Allison
Lee, Yoo Y.
Talaulikar, Dipti
Ku, Matthew
Wight, Joel
Tatarczuch, Maciej
Swain, Fiona
Gregory, Gareth P.
INTERNAL MEDICINE JOURNAL, 2022, 52 (09) : 1624 - 1632
[4] Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma
Connors, Joseph M.
BLOOD, 2015, 125 (11) : 1693 - 1702
[5] Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Lasica, Masa
Anderson, Mary A.
Boussioutas, Alex
Gregory, Gareth P.
Hamad, Nada
Manos, Kate
McKelvie, Penny
Ng, Michael
Campbell, Belinda
Palfreyman, Emma
Salvaris, Ross
Weinkove, Robert
Wight, Joel
Opat, Stephen
Tam, Constantine
INTERNAL MEDICINE JOURNAL, 2024, 54 (06) : 1017 - 1030
[6] Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Wight, Joel
Hamad, Nada
Campbell, Belinda A.
Ku, Matthew
Lee, Kenneth
Rose, Hannah
Armytage, Tasman
Latimer, Maya
Lee, Hui-Peng
Lee, Sze-Ting
Dickinson, Michael
Khor, Richard
Verner, Emma
INTERNAL MEDICINE JOURNAL, 2022, 52 (09) : 1609 - 1623
[7] Treatment of Newly Diagnosed Classical Hodgkin Lymphoma
Straus, David J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S87 - S88
[8] Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Hapgood, Greg
Latimer, Maya
Lee, Sze Ting
Kuss, Bryone
Lade, Stephen
Tobin, Joshua W. D.
Purtill, Duncan
Campbell, Belinda A.
Prince, H. Miles
Hawkes, Eliza A.
Shortt, Jake
Radeski, Dejan
INTERNAL MEDICINE JOURNAL, 2022, 52 (10) : 1806 - 1817
[9] Treatment of Newly-Diagnosed Classical Hodgkin Lymphoma
Straus, David J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S86 - S87
[10] Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study
Goh, Zhong
Latimer, Maya
Lewis, Katharine L.
Cheah, Chan Y.
Di Ciaccio, Pietro
Cushion, Tania
Hawkes, Eliza A.
Harrop, Sean
Ku, Matthew
Campbell, Ashlea
Hamad, Nada
Wood, Erica M.
Chung, Eliza
Chen, Pin-Yen
Cochrane, Tara
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (05): : 370 - 378

← 1 2 3 4 5 →